MicroBioLogics, Inc. Announces A Recapitalization With Granite Equity Partners

MicroBioLogics, Inc. is pleased to announce their new relationship with local investment group Granite Equity Partners. With the support of Granite Equity Partners, MicroBioLogics has reinforced their position as a leading producer of reference stock cultures for quality control microbiology and clinical diagnostic testing.

Granite Equity Partners is a Minnesota based private equity firm focused on buyouts, recapitalizations and growth equity investments. The Partners of Granite Equity have accumulated over four decades of experience and management expertise which will play a major role in the future growth and international expansion of MicroBioLogics.

Chief Executive Officer, Robert C. Coborn states, "MicroBioLogics is a true global leader in our market niche. This new year brings many exciting opportunities to MicroBioLogics. In early 2008 we introduced the MicroBioLogics License and Supply Program. We are currently in the final stages of receiving ISO 17025:2005 accreditation, and we continue to add international distribution partners to our commercial network. Granite Equity Partners will help us achieve our ambitious growth plans."

In this next phase of the Company's growth, two partners from Granite Equity will join MicroBioLogics as members of the Board of Directors. Their unique backgrounds with strong science and business leadership experience make them well suited to assist MicroBioLogics in facilitating growth and development strategies. Granite Equity Partners co-founder and partner Patrick K. Edeburn says, "MicroBioLogics is a strong company with a lot of potential for growth. We are happy to have this opportunity and look forward to a long-term partnership with them."

Mr. Coborn adds "We chose to work with Granite Equity Partners because they share our commitment to making a positive impact in our community and preserving the long- standing relationships we have built with our loyal employees. I am certain this relationship will give MicroBioLogics the means to realize its full potential."

About MicroBioLogics, Inc.
With more than 35 years of seasoned experience and a reputation for outstanding quality, MicroBioLogics specialize in manufacturing lyophilized microorganisms for clinical, pharmaceutical, cosmetic, food quality and environmental laboratories. They produce reference stock cultures and enumerated microorganism preparations that are dependable and traceable. MicroBioLogics currently has more than 50 employees at two locations. The company is an FDA registered establishment, conforms to CE Mark regulations and has achieved ISO 9001:2000 certification.

About Granite Equity Partners:
Granite Equity Partners is a private equity firm headquartered in St. Cloud, Minnesota. They specialize in financing buyouts, recapitalizations, and growth company transactions which include the sale or purchase of a business, generational transfers, or business expansions. Granite Equity Partners invests human and financial capital from its investors, executives, and advisors to advance select companies toward their full potential. The partners are a diverse group of experienced professionals who are committed to the success of the companies they invest in.

SOURCE: <%=company1%>